Saslow Debbie, Castle Philip E, Cox J Thomas, Davey Diane D, Einstein Mark H, Ferris Daron G, Goldie Sue J, Harper Diane M, Kinney Walter, Moscicki Anna-Barbara, Noller Kenneth L, Wheeler Cosette M, Ades Terri, Andrews Kimberly S, Doroshenk Mary K, Kahn Kelly Green, Schmidt Christy, Shafey Omar, Smith Robert A, Partridge Edward E, Garcia Francisco
Cancer Control Science Department, American Cancer Society, Altanta, GA, USA.
CA Cancer J Clin. 2007 Jan-Feb;57(1):7-28. doi: 10.3322/canjclin.57.1.7.
The American Cancer Society (ACS) has developed guidelines for the use of the prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical intraepithelial neoplasia and cervical cancer. These recommendations are based on a formal review of the available evidence. They address the use of prophylactic HPV vaccines, including who should be vaccinated and at what age, as well as a summary of policy and implementation issues. Implications for screening are also discussed.
美国癌症协会(ACS)制定了关于预防性人乳头瘤病毒(HPV)疫苗用于预防宫颈上皮内瘤变和宫颈癌的指南。这些建议基于对现有证据的正式审查。它们涉及预防性HPV疫苗的使用,包括哪些人应该接种疫苗以及在什么年龄接种,还总结了政策和实施问题。同时也讨论了对筛查的影响。